SE416470B - Analogiforfarande for framstellning av 3-substituerade as-triazino-(5,6-c)kinolinderivat - Google Patents

Analogiforfarande for framstellning av 3-substituerade as-triazino-(5,6-c)kinolinderivat

Info

Publication number
SE416470B
SE416470B SE7306320A SE7306320A SE416470B SE 416470 B SE416470 B SE 416470B SE 7306320 A SE7306320 A SE 7306320A SE 7306320 A SE7306320 A SE 7306320A SE 416470 B SE416470 B SE 416470B
Authority
SE
Sweden
Prior art keywords
triazino
substituted
preparation
quinoline derivatives
analogy procedure
Prior art date
Application number
SE7306320A
Other languages
English (en)
Swedish (sv)
Inventor
E Berenyt
L Pallos
L E Petocz
P Gorog
Z Budai
E Kiszelly
P Benko
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE416470B publication Critical patent/SE416470B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7306320A 1972-05-05 1973-05-04 Analogiforfarande for framstellning av 3-substituerade as-triazino-(5,6-c)kinolinderivat SE416470B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUEE2022A HU165678B (xx) 1972-05-05 1972-05-05

Publications (1)

Publication Number Publication Date
SE416470B true SE416470B (sv) 1981-01-05

Family

ID=10995440

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7306320A SE416470B (sv) 1972-05-05 1973-05-04 Analogiforfarande for framstellning av 3-substituerade as-triazino-(5,6-c)kinolinderivat

Country Status (16)

Country Link
US (1) US3873543A (xx)
JP (1) JPS523958B2 (xx)
AT (1) AT323747B (xx)
CA (1) CA963469A (xx)
CH (1) CH583234A5 (xx)
CS (1) CS174880B2 (xx)
DD (1) DD106843A5 (xx)
DE (1) DE2322486C2 (xx)
DK (1) DK143402C (xx)
FR (1) FR2183839B1 (xx)
GB (1) GB1401164A (xx)
HU (1) HU165678B (xx)
NL (1) NL165740C (xx)
PL (1) PL85373B1 (xx)
SE (1) SE416470B (xx)
YU (1) YU36373B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919215A (en) * 1974-11-04 1975-11-11 Dow Chemical Co 3-(2-Acylaminophenyl)-1,2,4-triazines
US3919216A (en) * 1974-11-04 1975-11-11 Dow Chemical Co 6-(Alkyl)-3,4,6,7-tetrahydro-1,2,4-triazinoquinazolines
US3919220A (en) * 1974-11-04 1975-11-11 Dow Chemical Co 6-(Phenyl and substituted phenyl)tetrahydro-1,2,4-triazinoquinazolines
US3919219A (en) * 1974-11-04 1975-11-11 Dow Chemical Co 6-Pyridyl-tetrahydro-1,2,4-triazinoquinazolines
US3922274A (en) * 1974-11-04 1975-11-25 Dow Chemical Co Dihydro-1,2,4-triazinoquinazolines
HU181689B (en) * 1980-04-18 1983-11-28 Egyt Gyogyszervegyeszeti Gyar Process for producing new dihydro-as-triazino-square bracket-5,6-c-square bracket closed-quinoline derivatives
WO2024094150A1 (en) * 2022-11-04 2024-05-10 Insilico Medicine Ip Limited Nlrp3 inflammasome inhibitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1449778A (fr) * 1965-06-28 1966-05-06 Nouveaux dérivés pyridotriaziniques utilisables comme stabilisants pour émulsions photographiques et procédé pour leur préparation
US3597427A (en) * 1969-01-13 1971-08-03 American Cyanamid Co 1,2-dihydropyrido(3,4-e)-as-triazines
US3721670A (en) * 1971-04-05 1973-03-20 Morton Norwich Products Inc 3-substituted-as-triazino(5,6-c)quinolines

Also Published As

Publication number Publication date
GB1401164A (en) 1975-07-16
JPS523958B2 (xx) 1977-01-31
HU165678B (xx) 1974-10-28
FR2183839B1 (xx) 1976-10-22
DK143402B (da) 1981-08-17
US3873543A (en) 1975-03-25
NL165740B (nl) 1980-12-15
JPS4947394A (xx) 1974-05-08
AT323747B (de) 1975-07-25
DE2322486C2 (de) 1982-06-03
DK143402C (da) 1981-12-21
NL7306283A (xx) 1973-11-07
YU118373A (en) 1981-11-13
NL165740C (nl) 1981-05-15
FR2183839A1 (xx) 1973-12-21
CH583234A5 (xx) 1976-12-31
PL85373B1 (en) 1976-04-30
YU36373B (en) 1983-06-30
DD106843A5 (xx) 1974-07-05
CA963469A (en) 1975-02-25
CS174880B2 (xx) 1977-04-29
DE2322486A1 (de) 1973-11-15

Similar Documents

Publication Publication Date Title
SE402592B (sv) Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner
SE432767B (sv) Forfarande for framstellning av oxazolo-(5,4-b)-pyridiner
NO144850C (no) Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater.
SE422325B (sv) Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat
NO140589C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 3,4-dihydrokarbostyrilderivater
SE422211B (sv) Analogiforfarande for framstellning av 2-acyl-4-pyrazino(2,1-a)isokinolin-derivat
SE424324B (sv) Analogiforfarande for framstellning av 1,2-benzisoxazolderivat
SE381047B (sv) Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE416811B (sv) Analogiforfarande for framstellning av nya, antibakteriellt aktiva derivat av amidinopenicillansyra
SE416470B (sv) Analogiforfarande for framstellning av 3-substituerade as-triazino-(5,6-c)kinolinderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE400278B (sv) Forfarande for framstellning av fenylketonderivat
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE373368B (sv) Forfarande for framstellning av 3-substituerade as-triazino(5,6-c)kinoliner
SE398351B (sv) Forfarande for framstellning av ditino-(1,4)-(2,3-c)pyrrol-piperazinderivat
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE423233B (sv) Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7504507L (sv) Forfarande for framstellning av 5-nitroimidazolderivat.
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat